| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | $98,4700 | +4,07 % | $1,44B | $174,92K | |
TMP Tompkins Financial Corporation | $98,1740 | -2,07 % | $1,44B | $31,17K | |
BRUN Boost Run Inc. Class A Common Stock | $18,8000 | -6,61 % | $1,44B | $2,20M | |
TWFG TWFG, Inc. Common Stock | $27,4400 | +2,47 % | $1,44B | $89,00K | |
PCT PureCycle Technologies, Inc. Common stock | $7,2550 | +5,45 % | $1,44B | $1,84M | |
REX REX American Resources Corp. | $44,0650 | -0,13 % | $1,43B | $40,00K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | $7,9010 | -5,38 % | $1,43B | $37,72K | |
BTT BlackRock Municipal 2030 Target Term Trust | $22,6500 | +0,27 % | $1,43B | $17,75K | |
ADNT Adient plc Ordinary Shares | $19,8700 | +2,00 % | $1,43B | $194,08K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | $26,9900 | -0,04 % | $1,43B | $1,83M | |
| $37,5580 | -0,01 % | $1,43B | $540,32K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | $2,8100 | -9,94 % | $1,43B | $455,01K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | $16,6010 | -2,40 % | $1,42B | $70,65K | |
REPL Replimune Group, Inc. | $14,9880 | -3,80 % | $1,42B | $2,28M | |
HCSG Healthcare Services Group | $22,9770 | +4,73 % | $1,42B | $324,77K | |
